AHA 2009 schedule

Here is the page we will use to coordinate interviews at AHA 2009

Filming location: Hilton Orlando 6001 Destination Parkway Orlando, FL 32819

Filming will occur from Saturday to Tuesday (November 14 - November 17). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides.

---

Click on Date for Detailed Schedule

Saturday November 14, 2009

Sunday November 15, 2009

Monday November 16, 2009

Tuesday November 17, 2009

---

Saturday, November 14, 2009

9:00 AM

• Interviewee: Rino Sardella
• Trial: Impact of Thrombectomy with EXPort Catheter in Infarct Related Artery during Primary PCI on Procedural Outcome in Patients with AMI (EXPIRA Trial). 24 Months Clinical Outcome

4:30 PM

Return to top

Sunday November 15, 2009

4:30 PM

• Interviewee: Philippe Meurin
• Trial: Non-Steroidal Anti-Inflammatory Treatment for Post-operative Pericardial Effusion: The POPE Study, A Multicenter, Double-blind, Randomized Trial

Return to top

Monday November 16, 2009

10:00 AM

• Interviewee: Christian Hamm
• Trial: PEPCAD III: A Randomized Trial Comparing a Paclitaxel-Coated Balloon/Stent System with a Sirolimus Eluting Stent

10:30 AM

• Interviewee: Cheuk-Man Yu
• Trial: Results of the Pacing to Avoid Cardiac Enlargement (PACE) Trial

11:00 AM

• Interviewee: Bruce Rollman
• Trial: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression: 8-Month Outcomes from The Bypassing The Blues Trial

2:00 PM

• Interviewee: Maria Brooks
• Trial: Quality of Life Results in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

4:30 PM

Return to top

Tuesday November 17, 2009

10:45 AM

• Interviewee: Deepak Bhatt
• Trial: CHAMPION PLATFORM Trial

4:30 PM

• Interviewee: Marvin Konstam
• Trial: Comparison of Low-Dose Versus High-Dose Losartan Treatment on Morbidity and Mortality in Angiotensin Converting Enzyme Inhibitor-Intolerant Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction: Results of the HEAAL Study

Return to top